Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization.

Publication date

2010

Authors

Schmitt, HeikeISNI 000000039053231X
Boucard, T.
Garric, J.
Jensen, J.
Parrott, J.
Pery, A.
Rombke, J.
Straub, J.O.
Hutchinson, T.H.
Sanchez-Arguello, P.

Editors

Advisors

Supervisors

Document Type

Article

License

Abstract

The effects testing of pharmaceuticals consists of a tiered investigation of ecotoxicological endpoints. However, effects testing has to be performed only when the predicted environmental concentrations (PECs) of pharmaceuticals are above certain action limits. To study the appropriateness of these action limits, a literature search was performed for pharmaceuticals with predicted no-effect concentrations (PNECs) close to or below the action limits. Some human pharmaceuticals showed effects at concentrations ≤100 ng/L, mostly in nonstandard fish or invertebrate tests. In addition, antibiotics and parasiticides sometimes had effects at concentrations

Keywords

Citation

Schmitt, H, Boucard, T, Garric, J, Jensen, J, Parrott, J, Pery, A, Rombke, J, Straub, J O, Hutchinson, T H, Sanchez-Arguello, P, Wennmalm, A & Duis, K 2010, 'Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization.', Integrated Environmental Assessment and Management, vol. 6, no. Suppl 1, pp. 588-602. https://doi.org/10.1897/IEAM_2009-053.1